Loading organizations...
Loading organizations...
Clinical-stage company developing therapies for sleep apnea.
Apnimed has raised $167.3M across 3 funding rounds.
Apnimed has raised $167.3M in total across 3 funding rounds.
Apnimed has raised $167.3M in total across 3 funding rounds.
Apnimed's investors include Chris Dimitropoulos, Sectoral Asset Management, Tao Capital Partners, Stefan Larson, Isaac Cheng, NexPoint, Seligman Private Equity Select, Morningside Ventures, Paul Wick, Nicholas Pritzker.
Apnimed has raised $167.3M across 3 funding rounds. Most recently, it raised $79.8M Series C Extension in January 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 3, 2023 | $79.8M Series C Extension | Chris Dimitropoulos | Sectoral Asset Management, Tao Capital Partners |
| May 4, 2022 | $62.5M Series C | Stefan Larson | Chris Dimitropoulos, Isaac Cheng, NexPoint, Seligman Private Equity Select, Tao Capital Partners |
| Mar 25, 2021 | $25.0M Series B | Morningside Ventures | Paul Wick, Nicholas Pritzker |